← Back to all trials
Not Yet Recruiting
NCT05666232
Renal and Cardiac Risk Factors of AKI After Liver Transplantation
Conditions: Acute Kidney Injury, Acute Renal Injury, Liver Transplant; Complications
Sex: All
Ages: 18 Years – 65 Years
Enrollment: 105
Sponsor: Mansoura University
Summary
Background: Liver transplantation (LT) is an extensive operation with various factors contributing to the development of acute kidney injury in the perioperative period.
Early diagnosis of AKI can improve clinical outcomes in LT recipients.
Renal resistive index is measured in renal arteries and high resistive values are associated with more adverse cardiovascular events and renal failure progression.
Myocardial performance index reflects overall cardiac function rather than systolic or diastolic function alone.Aim of the study: to investigate whether combined doppler renal resistive index and myocardial performance index could predict early postoperative acute kidney injury in living donor liver transplant recipients.Study design: a prospective observational study that will be conducted at Liver Transplantation Unit at Mansoura University on 105 consecutive living donor liver transplant recipients.Methods: Renal resistive index (assessed by transabdominal ultrasound) and myocardial performance index (assessed by transthoracic echocardiography) will be measured just before operation, on termination of operation and then daily in the intensive care unit for 7 days.
Patients will be observed for development of acute kidney injury.
Eligibility Criteria
Inclusion Criteria:patients undergoing right-lobe living-donor liver transplantationExclusion Criteria:preoperative renal impairment (GFR < 60 ml/min/1.73
m2)known renal artery stenosispatient who underwent previous nephrectomyischemic heart disease (patient who takes anti-ischemic measures as prescribed by a consultant cardiologist)Patient with arrthymia or who develop persistent intraoperative arrythmia
Source: ClinicalTrials.gov (NCT05666232). StuddyBuddy aggregates publicly available trial information.